ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	18/150	191/7206	6.99569793912e-08
ko04621	NOD-like receptor signaling pathway	16/150	157/7206	1.32863221844e-07
ko04668	TNF signaling pathway	14/150	120/7206	1.56811586745e-07
ko05164	Influenza A	16/150	167/7206	3.13473697581e-07
ko04623	Cytosolic DNA-sensing pathway	7/150	41/7206	1.82811618726e-05
ko04380	Osteoclast differentiation	12/150	134/7206	2.0233736112e-05
ko04064	NF-kappa B signaling pathway	10/150	96/7206	2.75681626534e-05
ko05160	Hepatitis C	12/150	153/7206	7.54699945594e-05
ko04210	Apoptosis	13/150	180/7206	8.83863624714e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	13/150	191/7206	0.000161133155891
ko05162	Measles	10/150	120/7206	0.000185218390801
ko04660	T cell receptor signaling pathway	10/150	124/7206	0.00024255546873
ko05161	Hepatitis B	12/150	173/7206	0.000243040020958
ko04622	RIG-I-like receptor signaling pathway	7/150	62/7206	0.000277541960564
ko04630	Jak-STAT signaling pathway	10/150	132/7206	0.000402510731135
ko04620	Toll-like receptor signaling pathway	8/150	100/7206	0.0010795956822
ko05168	Herpes simplex infection	11/150	182/7206	0.0013927297734
ko04657	IL-17 signaling pathway	7/150	87/7206	0.0021396096756
ko04931	Insulin resistance	9/150	137/7206	0.00214763126232
ko04662	B cell receptor signaling pathway	7/150	88/7206	0.00228476348328
ko05323	Rheumatoid arthritis	7/150	89/7206	0.00243740879876
ko00643	Styrene degradation	2/150	4/7206	0.00251264934623
ko04062	Chemokine signaling pathway	11/150	201/7206	0.00305274056003
ko05134	Legionellosis	6/150	74/7206	0.00425752339383
ko04115	p53 signaling pathway	6/150	74/7206	0.00425752339383
ko04672	Intestinal immune network for IgA production	4/150	37/7206	0.00698586324978
ko05131	Shigellosis	6/150	82/7206	0.00702857674496
ko04917	Prolactin signaling pathway	6/150	87/7206	0.00931565104292
ko05221	Acute myeloid leukemia	5/150	63/7206	0.00974871553888
ko00051	Fructose and mannose metabolism	4/150	42/7206	0.0109294692585
ko04217	Necroptosis	9/150	178/7206	0.0117715720498
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/150	92/7206	0.0120914431344
ko04080	Neuroactive ligand-receptor interaction	2/150	423/7206	0.0124575026985
ko04932	Non-alcoholic fatty liver disease (NAFLD)	9/150	182/7206	0.0134711040047
ko04211	Longevity regulating pathway	7/150	123/7206	0.0140185954973
ko04658	Th1 and Th2 cell differentiation	6/150	96/7206	0.0146969802497
ko04650	Natural killer cell mediated cytotoxicity	6/150	97/7206	0.0154049541618
ko05132	Salmonella infection	6/150	98/7206	0.0161362848006
ko05142	Chagas disease (American trypanosomiasis)	7/150	130/7206	0.0185034584313
ko05166	HTLV-I infection	12/150	292/7206	0.0202825163827
ko04068	FoxO signaling pathway	8/150	167/7206	0.0229668554193
ko05340	Primary immunodeficiency	3/150	30/7206	0.0237996969781
ko05215	Prostate cancer	6/150	111/7206	0.0279185382761
ko05133	Pertussis	5/150	87/7206	0.0345736267558
ko04670	Leukocyte transendothelial migration	7/150	151/7206	0.0378194712737
ko05150	Staphylococcus aureus infection	3/150	36/7206	0.0382584611629
ko04020	Calcium signaling pathway	1/150	265/7206	0.0454540393316
ko05145	Toxoplasmosis	6/150	126/7206	0.0473084655242